We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $5.62B
1-Year Est. Return 36.06%
This Fund
S&P 500
This Quarter Est. Return
-0.89%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$849M
AUM Growth
+$64.3M
Cap. Flow
+$67.4M
Cap. Flow %
7.94%
Top 10 Hldgs %
45.35%
Holding
87
New
28
Increased
23
Reduced
11
Closed
22

Top Buys

Rank Stock Value
1
UTHR icon
United Therapeutics
UTHR
+$19.2M
2
INCY icon
Incyte
INCY
+$18.5M
3
ASRT
Assertio
ASRT
+$17.4M
4
DKS icon
Dick's Sporting Goods
DKS
+$15.9M
5
CPB icon
Campbell Soup
CPB
+$15M

Top Sells

Rank Stock Value
1
HAIN icon
Hain Celestial
HAIN
+$27.8M
2
SGI
Somnigroup International
SGI
+$20.7M
3
PRKS icon
United Parks & Resorts
PRKS
+$13.7M
4
GCI
Gannett Co., Inc
GCI
+$13.4M
5
ALXN
Alexion Pharmaceuticals
ALXN
+$12.2M

Sector Composition

Rank Sector Weight
1 Healthcare 30.77%
2 Consumer Discretionary 18.98%
3 Consumer Staples 9.7%
4 Industrials 3.8%
5 Technology 0.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TSN icon
51
Tyson Foods
TSN
$21.4B
$3.52M 0.42%
50,000
-110,000
-69% -$7.03M
PIR
52
DELISTED
Pier 1 Imports, Inc.
PIR
$3.52M 0.41%
+42,000
New +$3.76M
EGLT
53
DELISTED
Egalet Corporation
EGLT
$2.62M 0.31%
+2,050,000
New +$2.74M
ATNM icon
54
Actinium Pharmaceuticals
ATNM
$26.8M
$2.52M 0.3%
+146,067
New +$3.21M
SEEL
55
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
$2.48M 0.29%
+13
New +$2.13M
MNTA
56
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
$2.44M 0.29%
132,000
-688,000
-84% -$11.5M
KPRX icon
57
Kiora Pharmaceuticals
KPRX
$11.3M
$1.89M 0.22%
299
– –
ATEC icon
58
Alphatec Holdings
ATEC
$1.33B
$1.49M 0.18%
658,414
+122,000
+23% +$235K
LRMR icon
59
Larimar Therapeutics
LRMR
$398M
$1.34M 0.16%
+31,667
New +$1.32M
DYNT
60
DELISTED
Dynatronics Corp
DYNT
$1.15M 0.14%
102,024
+2,024
+2% +$25.9K
VXRT
61
DELISTED
Vaxart
VXRT
$944K 0.11%
125,315
+23,240
+23% +$158K
AIXC
62
AIxCrypto Holdings Inc
AIXC
$16.7M
$665K 0.08%
+15
New +$1.05M
ADMS
63
CALL
DELISTED
Adamas Pharmaceuticals
ADMS
$550K 0.06%
+26,000
New +$477K
OPGN
64
DELISTED
OpGen, Inc
OPGN
$144K 0.02%
+5
New +$160K
ANF icon
65
CALL
Abercrombie & Fitch
ANF
$4.41B
– –
-500,000
Closed -$6.22M
BBY icon
66
Best Buy
BBY
$18.6B
– –
-200,000
Closed -$11.5M
BURL icon
67
Burlington
BURL
$22.5B
– –
-36,000
Closed -$3.31M
BBBY
68
Bed Bath & Beyond
BBBY
$512M
– –
-244,904
Closed -$3M
CRI icon
69
Carter's
CRI
$1.43B
– –
-78,000
Closed -$6.94M
DG icon
70
Dollar General
DG
$27.2B
– –
-140,000
Closed -$10.1M
HAIN icon
71
Hain Celestial
HAIN
$46M
– –
-672,000
Closed -$27.8M
JILL icon
72
J. Jill
JILL
$261M
– –
-31,442
Closed -$1.62M
LOCO icon
73
El Pollo Loco
LOCO
$493M
– –
-700,000
Closed -$9.7M
PINC
74
DELISTED
Premier
PINC
– –
-182,000
Closed -$6.55M
PRKS icon
75
United Parks & Resorts
PRKS
$2.12B
– –
-1,000,000
Closed -$13.7M
1 2
3
4

Similar funds

CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
RMDI
R.M. Davis Inc Portland, Maine $5.63B AUM 21.26% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
DWM
Diversify Wealth Management Sandy, Utah $5.61B AUM 19.63% 1-Year Est. Return
DCP
DSM Capital Partners Palm Beach Gardens, Florida $5.66B AUM 27.45% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $5.57B AUM 23.85% 1-Year Est. Return
AIM
Alphinity Investment Management Sydney, Australia $5.68B AUM 26.72% 1-Year Est. Return
O
Ossiam Paris, France $5.69B AUM 30.95% 1-Year Est. Return

Armistice Capital's Q3 2017 Portfolio in Review

As of Q3 2017, Armistice Capital held 87 positions worth $849M, up 8.2% from $785M the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Armistice Capital deployed $67.4M of net new capital in Q3 2017, opening 28 new positions and adding to 23 existing holdings. Its largest new stake was United Therapeutics: 150,000 shares worth $17.6M.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, down from 32% a quarter earlier, followed by Consumer Discretionary and Consumer Staples.

On the sell side, the largest reduction was Momenta Pharmaceuticals, Inc., an estimated $11.5M trimmed.

  • Armistice Capital's largest Q3 2017 buy was United Therapeutics: 150,000 shares worth $17.6M.
  • Armistice Capital added most to Assertio in Q3 2017, an estimated $17.4M increase.
  • Armistice Capital's biggest Q3 2017 reduction was Momenta Pharmaceuticals, Inc., cutting an estimated $11.5M.
  • Armistice Capital fully exited Hain Celestial in Q3 2017, selling an estimated $27.8M.
  • Armistice Capital's ten largest holdings make up 45% of its $849M portfolio in Q3 2017.
  • Armistice Capital opened 28 new positions and closed 22 in Q3 2017.
  • Armistice Capital's portfolio value rose 8.2% quarter-over-quarter to $849M.

Based on Armistice Capital's 13F filing for Q3 2017, filed 14 Nov 2017.